Daily Stock Analysis, AVGR, Avinger Inc, priceseries

Avinger Inc. Daily Stock Analysis
Stock Information
Open
2.45
Close
2.40
High
2.55
Low
2.40
Previous Close
2.40
Daily Price Gain
0.00
YTD High
4.24
YTD High Date
Jan 5, 2017
YTD Low
2.00
YTD Low Date
Jan 24, 2017
YTD Price Change
-1.35
YTD Gain
-36.00%
52 Week High
17.89
52 Week High Date
Feb 22, 2016
52 Week Low
2.00
52 Week Low Date
Jan 24, 2017
52 Week Price Change
-13.27
52 Week Gain
-84.68%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 29. 2015
11.68
Jun 12. 2015
12.28
10 Trading Days
5.11%
Link
LONG
Jul 27. 2015
13.39
Aug 6. 2015
14.72
8 Trading Days
9.96%
Link
LONG
Apr 6. 2016
10.78
Apr 20. 2016
12.15
10 Trading Days
12.69%
Link
LONG
Aug 17. 2016
4.40
Aug 19. 2016
4.62
2 Trading Days
5.11%
Link
LONG
Dec 19. 2016
4.05
Dec 22. 2016
4.30
3 Trading Days
6.17%
Link
Company Information
Stock Symbol
AVGR
Exchange
NasdaqGM
Company URL
http://www.avinger.com
Company Phone
650-363-2400
CEO
Jeff M. Soinski
Headquarters
California
Business Address
400 CHESAPEAKE DRIVE, REDWOOD CITY, CA 94063
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001506928
About

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe.

Description

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. The company develops lumivascular platform, which integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products include the Lightbox imaging console and Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions (CTOs). The company is also developing Pantheris, an image-guided atherectomy device, which is designed to precisely remove arterial plaque in PAD patients. In addition, its first-generation CTO-crossing catheters, Wildcat and Kittycat 2, employ a proprietary design that uses a rotational spinning technique, allowing the physician to switch between a passive and active mode when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.